Reference number : 276-2016-2017-Q3-00282, amendment number : , agreement type : C, recipient legal name : Institut atlantique de recherche sur le cancer inc. / Atlantic Cancer Research I|Institut atlantique de recherche sur le cancer inc. / Atlantic Cancer Research I, recipient country : CA, recipient province : NB, recipient city : Moncton|Moncton, recipient postal code : E1C 8X3, program name english : Atlantic Innovation Fund (AIF) - II, program name french : Fonds d'innovation de l'Atlantique (FIA) - II, program purpose english : nan, program purpose french : nan, agreement title english : 207369, agreement title french : 207369, agreement number : 207369, agreement value : 3000000.0, agreement start date : 2016-12-22, agreement end date : 2020-03-27, description english : Deliver precision medicine through liquid biopsy technologies, description french : Offrir de la médecine de précision grâce à des technologies de biopsie liquide, expected results english : nan, expected results french : nan, additional information english : The assistance type is Non-Repayable Contribution. The total government funding is $3,500,000.00., additional information french : Le type d'aide est Contribution non remboursable. Le financement gouvernemental total est 3 500 000,00 $., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique